Novel motif:161
From FANTOM5_SSTAR
name: | motif161_CGGCTTGATT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 6.224177e-10 |
GO:0090086 | negative regulation of protein deubiquitination | 4.404815e-9 |
GO:0009084 | glutamine family amino acid biosynthetic process | 7.799066e-9 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 1.107606e-8 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 1.107606e-8 |
GO:0090085 | regulation of protein deubiquitination | 1.609274e-8 |
GO:0030433 | ER-associated protein catabolic process | 2.082875e-8 |
GO:0051382 | kinetochore assembly | 2.711195e-8 |
GO:0051383 | kinetochore organization | 5.515273e-8 |
GO:0031116 | positive regulation of microtubule polymerization | 6.313938e-8 |
GO:0021570 | rhombomere 4 development | 7.108751e-8 |
GO:0010561 | negative regulation of glycoprotein biosynthetic process | 1.211038e-7 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 1.387916e-7 |
GO:0021569 | rhombomere 3 development | 1.460671e-7 |
GO:0043316 | cytotoxic T cell degranulation | 1.467622e-7 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 1.467622e-7 |
GO:0034976 | response to endoplasmic reticulum stress | 2.212298e-7 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 2.385666e-7 |
GO:0021599 | abducens nerve formation | 2.385666e-7 |
GO:0007634 | optokinetic behavior | 2.385666e-7 |
GO:0002115 | store-operated calcium entry | 4.488657e-7 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 6.678267e-7 |
GO:0050668 | positive regulation of homocysteine metabolic process | 6.684106e-7 |
GO:0045963 | negative regulation of dopamine metabolic process | 6.684106e-7 |
GO:0061384 | heart trabecular morphogenesis | 6.820397e-7 |
GO:0034699 | response to luteinizing hormone stimulus | 1.048196e-6 |
GO:0050652 | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1.048196e-6 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 1.130212e-6 |
GO:0006986 | response to unfolded protein | 1.387555e-6 |
GO:0021612 | facial nerve structural organization | 1.431352e-6 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 1.601103e-6 |
GO:0042026 | protein refolding | 1.656093e-6 |
GO:0022600 | digestive system process | 1.786411e-6 |
GO:0034637 | cellular carbohydrate biosynthetic process | 1.795289e-6 |
GO:0034508 | centromere complex assembly | 2.068668e-6 |
GO:0010459 | negative regulation of heart rate | 2.239845e-6 |
GO:0050666 | regulation of homocysteine metabolic process | 2.334316e-6 |
GO:0030101 | natural killer cell activation | 2.406885e-6 |
GO:0002285 | lymphocyte activation involved in immune response | 3.171872e-6 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 3.427226e-6 |
GO:0043320 | natural killer cell degranulation | 4.162023e-6 |
GO:0001578 | microtubule bundle formation | 5.237774e-6 |
GO:0021602 | cranial nerve morphogenesis | 6.017855e-6 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 6.179545e-6 |
GO:0060347 | heart trabecula formation | 6.349992e-6 |
GO:0090183 | regulation of kidney development | 6.677529e-6 |
GO:0051967 | negative regulation of synaptic transmission, glutamatergic | 7.309200e-6 |
GO:0048676 | axon extension involved in development | 7.351774e-6 |
GO:0090281 | negative regulation of calcium ion import | 7.564613e-6 |
GO:0071584 | negative regulation of zinc ion import | 7.564613e-6 |
GO:0007586 | digestion | 8.041201e-6 |
GO:0042267 | natural killer cell mediated cytotoxicity | 9.319660e-6 |
GO:0010734 | negative regulation of protein glutathionylation | 9.761260e-6 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 9.844655e-6 |
GO:0051310 | metaphase plate congression | 1.083290e-5 |
GO:0033240 | positive regulation of cellular amine metabolic process | 1.097966e-5 |
GO:0032203 | telomere formation via telomerase | 1.103480e-5 |
GO:0048532 | anatomical structure arrangement | 1.223457e-5 |
GO:0032230 | positive regulation of synaptic transmission, GABAergic | 1.426828e-5 |
GO:0060876 | semicircular canal formation | 1.500801e-5 |
GO:0034766 | negative regulation of ion transmembrane transport | 1.697557e-5 |
GO:0035966 | response to topologically incorrect protein | 1.891767e-5 |
GO:0006797 | polyphosphate metabolic process | 1.915958e-5 |
GO:0021546 | rhombomere development | 1.991344e-5 |
GO:0048639 | positive regulation of developmental growth | 2.037916e-5 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 2.075835e-5 |
GO:0007518 | myoblast cell fate determination | 2.466523e-5 |
GO:0032237 | activation of store-operated calcium channel activity | 2.512381e-5 |
GO:0045116 | protein neddylation | 2.549812e-5 |
GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 2.827345e-5 |
GO:0031113 | regulation of microtubule polymerization | 2.986889e-5 |
GO:0021610 | facial nerve morphogenesis | 2.992379e-5 |
GO:0021603 | cranial nerve formation | 3.046078e-5 |
GO:0061162 | establishment of monopolar cell polarity | 3.181376e-5 |
GO:0045927 | positive regulation of growth | 3.183199e-5 |
GO:0060676 | ureteric bud formation | 3.242733e-5 |
GO:0060300 | regulation of cytokine activity | 3.642847e-5 |
GO:0048793 | pronephros development | 3.921833e-5 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 4.085535e-5 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 4.085535e-5 |
GO:0071585 | detoxification of cadmium ion | 4.568540e-5 |
GO:0021561 | facial nerve development | 4.924189e-5 |
GO:0051654 | establishment of mitochondrion localization | 5.321877e-5 |
GO:0000236 | mitotic prometaphase | 5.322265e-5 |
GO:0030509 | BMP signaling pathway | 5.429249e-5 |
GO:0006537 | glutamate biosynthetic process | 5.695615e-5 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 6.327810e-5 |
GO:0002312 | B cell activation involved in immune response | 7.258731e-5 |
GO:0006421 | asparaginyl-tRNA aminoacylation | 7.775831e-5 |
GO:0090084 | negative regulation of inclusion body assembly | 7.809780e-5 |
GO:0048144 | fibroblast proliferation | 8.504764e-5 |
GO:0072205 | metanephric collecting duct development | 8.905504e-5 |
GO:0001909 | leukocyte mediated cytotoxicity | 9.033504e-5 |
GO:0033120 | positive regulation of RNA splicing | 9.114967e-5 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 9.642439e-5 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 1.023565e-4 |
GO:0009304 | tRNA transcription | 1.054696e-4 |
GO:0002316 | follicular B cell differentiation | 1.054696e-4 |
GO:0021604 | cranial nerve structural organization | 1.103780e-4 |
GO:0006542 | glutamine biosynthetic process | 1.162105e-4 |
GO:2000353 | positive regulation of endothelial cell apoptosis | 1.187115e-4 |
GO:0016051 | carbohydrate biosynthetic process | 1.190829e-4 |
GO:0009236 | cobalamin biosynthetic process | 1.222616e-4 |
GO:0045822 | negative regulation of heart contraction | 1.279977e-4 |
GO:0051973 | positive regulation of telomerase activity | 1.312573e-4 |
GO:0047497 | mitochondrion transport along microtubule | 1.349536e-4 |
GO:0006268 | DNA unwinding involved in replication | 1.404500e-4 |
GO:0021754 | facial nucleus development | 1.453214e-4 |
GO:0060301 | positive regulation of cytokine activity | 1.546427e-4 |
GO:0046184 | aldehyde biosynthetic process | 1.546427e-4 |
GO:0006538 | glutamate catabolic process | 1.664979e-4 |
GO:0006457 | protein folding | 1.883894e-4 |
GO:0001832 | blastocyst growth | 1.927128e-4 |
GO:0033692 | cellular polysaccharide biosynthetic process | 1.954768e-4 |
GO:0072215 | regulation of metanephros development | 1.998595e-4 |
GO:0072060 | outer medullary collecting duct development | 2.000195e-4 |
GO:0072061 | inner medullary collecting duct development | 2.000195e-4 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 2.000195e-4 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 2.000195e-4 |
GO:0072110 | glomerular mesangial cell proliferation | 2.048531e-4 |
GO:0002456 | T cell mediated immunity | 2.207453e-4 |
GO:0048754 | branching morphogenesis of a tube | 2.248334e-4 |
GO:0002366 | leukocyte activation involved in immune response | 2.312848e-4 |
GO:0060318 | definitive erythrocyte differentiation | 2.328483e-4 |
GO:0043501 | skeletal muscle adaptation | 2.404243e-4 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 2.501701e-4 |
GO:0009620 | response to fungus | 2.593368e-4 |
GO:0048638 | regulation of developmental growth | 2.595853e-4 |
GO:0090083 | regulation of inclusion body assembly | 2.653262e-4 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 2.697708e-4 |
GO:0035115 | embryonic forelimb morphogenesis | 2.716181e-4 |
GO:0046007 | negative regulation of activated T cell proliferation | 2.757253e-4 |
GO:0032202 | telomere assembly | 2.855563e-4 |
GO:0032660 | regulation of interleukin-17 production | 3.221671e-4 |
GO:0045907 | positive regulation of vasoconstriction | 3.407746e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 3.552534e-4 |
GO:0046541 | saliva secretion | 3.552534e-4 |
GO:0071506 | cellular response to mycophenolic acid | 3.552534e-4 |
GO:0051156 | glucose 6-phosphate metabolic process | 3.654638e-4 |
GO:0007522 | visceral muscle development | 3.701400e-4 |
GO:0070925 | organelle assembly | 3.834859e-4 |
GO:0035136 | forelimb morphogenesis | 3.869393e-4 |
GO:0030308 | negative regulation of cell growth | 3.888864e-4 |
GO:0045764 | positive regulation of cellular amino acid metabolic process | 3.940656e-4 |
GO:0035117 | embryonic arm morphogenesis | 3.940656e-4 |
GO:0014888 | striated muscle adaptation | 3.948389e-4 |
GO:0000733 | DNA strand renaturation | 4.086744e-4 |
GO:0061387 | regulation of extent of cell growth | 4.288638e-4 |
GO:0032958 | inositol phosphate biosynthetic process | 4.319817e-4 |
GO:0043266 | regulation of potassium ion transport | 4.321934e-4 |
GO:0050849 | negative regulation of calcium-mediated signaling | 4.359062e-4 |
GO:0060074 | synapse maturation | 4.402461e-4 |
GO:0045773 | positive regulation of axon extension | 4.521407e-4 |
GO:0033239 | negative regulation of cellular amine metabolic process | 4.656207e-4 |
GO:0032224 | positive regulation of synaptic transmission, cholinergic | 4.656207e-4 |
GO:0061084 | negative regulation of protein refolding | 4.776372e-4 |
GO:0072109 | glomerular mesangium development | 4.776372e-4 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 4.989441e-4 |
GO:0030516 | regulation of axon extension | 5.090989e-4 |
GO:0060356 | leucine import | 5.115825e-4 |
GO:0007059 | chromosome segregation | 5.145444e-4 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 5.211846e-4 |
GO:0072044 | collecting duct development | 5.212449e-4 |
GO:0000085 | G2 phase of mitotic cell cycle | 5.270117e-4 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 5.557213e-4 |
GO:0034441 | plasma lipoprotein particle oxidation | 6.021531e-4 |
GO:0032236 | positive regulation of calcium ion transport via store-operated calcium channel activity | 6.048628e-4 |
GO:0043484 | regulation of RNA splicing | 6.049534e-4 |
GO:0007064 | mitotic sister chromatid cohesion | 6.067609e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 6.143754e-4 |
GO:0060629 | regulation of homologous chromosome segregation | 6.495199e-4 |
GO:0051598 | meiotic recombination checkpoint | 6.495199e-4 |
GO:0050703 | interleukin-1 alpha secretion | 6.948275e-4 |
GO:0002729 | positive regulation of natural killer cell cytokine production | 6.948275e-4 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 6.985497e-4 |
GO:0002313 | mature B cell differentiation involved in immune response | 7.075056e-4 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 7.152771e-4 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 7.396185e-4 |
GO:0035967 | cellular response to topologically incorrect protein | 7.403598e-4 |
GO:0002026 | regulation of the force of heart contraction | 7.403598e-4 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 7.545146e-4 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 7.629213e-4 |
GO:0021545 | cranial nerve development | 7.700435e-4 |
GO:0046364 | monosaccharide biosynthetic process | 7.834690e-4 |
GO:0030307 | positive regulation of cell growth | 7.918224e-4 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 8.186859e-4 |
GO:0070884 | regulation of calcineurin-NFAT signaling pathway | 8.495929e-4 |
GO:0043268 | positive regulation of potassium ion transport | 9.177952e-4 |
GO:0030277 | maintenance of gastrointestinal epithelium | 9.214181e-4 |
GO:0046929 | negative regulation of neurotransmitter secretion | 9.464532e-4 |
GO:0019319 | hexose biosynthetic process | 9.564517e-4 |
GO:0002769 | natural killer cell inhibitory signaling pathway | 9.573565e-4 |
GO:0051775 | response to redox state | 9.903122e-4 |
GO:0021783 | preganglionic parasympathetic nervous system development | 1.000752e-3 |
GO:0014012 | peripheral nervous system axon regeneration | 1.000752e-3 |
GO:0061138 | morphogenesis of a branching epithelium | 1.003053e-3 |
GO:0048675 | axon extension | 1.015292e-3 |
GO:0060482 | lobar bronchus development | 1.043467e-3 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 1.048374e-3 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 1.056658e-3 |
GO:0071398 | cellular response to fatty acid | 1.061366e-3 |
GO:0046884 | follicle-stimulating hormone secretion | 1.088457e-3 |
GO:0032275 | luteinizing hormone secretion | 1.088457e-3 |
GO:0072668 | tubulin complex biogenesis | 1.102218e-3 |
GO:0002027 | regulation of heart rate | 1.102231e-3 |
GO:0072283 | metanephric renal vesicle morphogenesis | 1.190069e-3 |
GO:0045660 | positive regulation of neutrophil differentiation | 1.245647e-3 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 1.260671e-3 |
GO:0006084 | acetyl-CoA metabolic process | 1.264729e-3 |
GO:0033119 | negative regulation of RNA splicing | 1.287045e-3 |
GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1.301329e-3 |
GO:0060628 | regulation of ER to Golgi vesicle-mediated transport | 1.343925e-3 |
GO:0070574 | cadmium ion transmembrane transport | 1.347635e-3 |
GO:0072087 | renal vesicle development | 1.362768e-3 |
GO:0060992 | response to fungicide | 1.371104e-3 |
GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 1.391667e-3 |
GO:0043950 | positive regulation of cAMP-mediated signaling | 1.418985e-3 |
GO:0007495 | visceral mesoderm-endoderm interaction involved in midgut development | 1.418985e-3 |
GO:0001833 | inner cell mass cell proliferation | 1.423844e-3 |
GO:0002238 | response to molecule of fungal origin | 1.424584e-3 |
GO:0051646 | mitochondrion localization | 1.431340e-3 |
GO:0001696 | gastric acid secretion | 1.463071e-3 |
GO:0007026 | negative regulation of microtubule depolymerization | 1.514371e-3 |
GO:0060560 | developmental growth involved in morphogenesis | 1.540772e-3 |
GO:0035409 | histone H3-Y41 phosphorylation | 1.542080e-3 |
GO:0008636 | activation of caspase activity by protein phosphorylation | 1.542080e-3 |
GO:0014732 | skeletal muscle atrophy | 1.586069e-3 |
GO:0001824 | blastocyst development | 1.649469e-3 |
GO:0050922 | negative regulation of chemotaxis | 1.657656e-3 |
GO:0021636 | trigeminal nerve morphogenesis | 1.716961e-3 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1.750066e-3 |
GO:0010959 | regulation of metal ion transport | 1.925513e-3 |
GO:0072077 | renal vesicle morphogenesis | 1.931496e-3 |
GO:0031114 | regulation of microtubule depolymerization | 1.985736e-3 |
GO:0003338 | metanephros morphogenesis | 2.001722e-3 |
GO:0048554 | positive regulation of metalloenzyme activity | 2.003787e-3 |
GO:0018027 | peptidyl-lysine dimethylation | 2.003787e-3 |
GO:0032024 | positive regulation of insulin secretion | 2.009838e-3 |
GO:0061077 | chaperone-mediated protein folding | 2.034370e-3 |
GO:0090277 | positive regulation of peptide hormone secretion | 2.078688e-3 |
GO:0048739 | cardiac muscle fiber development | 2.079263e-3 |
GO:0019408 | dolichol biosynthetic process | 2.158600e-3 |
GO:0071481 | cellular response to X-ray | 2.160414e-3 |
GO:0048305 | immunoglobulin secretion | 2.160414e-3 |
GO:0010388 | cullin deneddylation | 2.298181e-3 |
GO:0007023 | post-chaperonin tubulin folding pathway | 2.298719e-3 |
GO:0007050 | cell cycle arrest | 2.324931e-3 |
GO:0071526 | semaphorin-plexin signaling pathway | 2.348011e-3 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 2.360413e-3 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 2.364663e-3 |
GO:0050746 | regulation of lipoprotein metabolic process | 2.364663e-3 |
GO:0010477 | response to sulfur dioxide | 2.379266e-3 |
GO:0002457 | T cell antigen processing and presentation | 2.379266e-3 |
GO:0002793 | positive regulation of peptide secretion | 2.394095e-3 |
GO:0009150 | purine ribonucleotide metabolic process | 2.402939e-3 |
GO:0061383 | trabecula morphogenesis | 2.440934e-3 |
GO:0009404 | toxin metabolic process | 2.459984e-3 |
GO:0009154 | purine ribonucleotide catabolic process | 2.493923e-3 |
GO:0006264 | mitochondrial DNA replication | 2.509112e-3 |
GO:0045786 | negative regulation of cell cycle | 2.590712e-3 |
GO:0051303 | establishment of chromosome localization | 2.641274e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 2.644815e-3 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 2.644815e-3 |
GO:0009141 | nucleoside triphosphate metabolic process | 2.665136e-3 |
GO:0061010 | gall bladder development | 2.733633e-3 |
GO:0035261 | external genitalia morphogenesis | 2.733633e-3 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 2.733633e-3 |
GO:0030259 | lipid glycosylation | 2.743285e-3 |
GO:0055091 | phospholipid homeostasis | 2.751506e-3 |
GO:0009261 | ribonucleotide catabolic process | 2.818746e-3 |
GO:0002121 | inter-male aggressive behavior | 2.853466e-3 |
GO:0017085 | response to insecticide | 2.868940e-3 |
GO:0046887 | positive regulation of hormone secretion | 2.888005e-3 |
GO:0001834 | trophectodermal cell proliferation | 2.926723e-3 |
GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 2.926723e-3 |
GO:0007402 | ganglion mother cell fate determination | 2.926723e-3 |
GO:0048486 | parasympathetic nervous system development | 2.941705e-3 |
GO:0048012 | hepatocyte growth factor receptor signaling pathway | 3.019161e-3 |
GO:0002335 | mature B cell differentiation | 3.046531e-3 |
GO:0043615 | astrocyte cell migration | 3.090021e-3 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.090021e-3 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 3.160842e-3 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 3.206878e-3 |
GO:0010159 | specification of organ position | 3.227377e-3 |
GO:0090279 | regulation of calcium ion import | 3.276346e-3 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 3.293509e-3 |
GO:0043508 | negative regulation of JUN kinase activity | 3.303577e-3 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 3.307817e-3 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 3.335732e-3 |
GO:0007217 | tachykinin receptor signaling pathway | 3.386953e-3 |
GO:0009636 | response to toxin | 3.423020e-3 |
GO:0009313 | oligosaccharide catabolic process | 3.472680e-3 |
GO:0048588 | developmental cell growth | 3.636248e-3 |
GO:0042632 | cholesterol homeostasis | 3.643807e-3 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 3.669287e-3 |
GO:0061038 | uterus morphogenesis | 3.678001e-3 |
GO:0070509 | calcium ion import | 3.778306e-3 |
GO:0050804 | regulation of synaptic transmission | 3.783891e-3 |
GO:0060904 | regulation of protein folding in endoplasmic reticulum | 3.801771e-3 |
GO:0070060 | 'de novo' actin filament nucleation | 3.801771e-3 |
GO:0039020 | pronephric nephron tubule development | 3.801771e-3 |
GO:0035565 | regulation of pronephros size | 3.801771e-3 |
GO:0021589 | cerebellum structural organization | 3.801771e-3 |
GO:0045591 | positive regulation of regulatory T cell differentiation | 3.863052e-3 |
GO:0070914 | UV-damage excision repair | 3.863052e-3 |
GO:0051177 | meiotic sister chromatid cohesion | 3.863052e-3 |
GO:0043060 | meiotic metaphase I plate congression | 3.863052e-3 |
GO:0019242 | methylglyoxal biosynthetic process | 3.863052e-3 |
GO:0032228 | regulation of synaptic transmission, GABAergic | 3.973909e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 4.088567e-3 |
GO:0048702 | embryonic neurocranium morphogenesis | 4.088567e-3 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 4.143661e-3 |
GO:0031915 | positive regulation of synaptic plasticity | 4.272850e-3 |
GO:0071985 | multivesicular body sorting pathway | 4.351991e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 4.351991e-3 |
GO:0018022 | peptidyl-lysine methylation | 4.351991e-3 |
GO:0060399 | positive regulation of growth hormone receptor signaling pathway | 4.399288e-3 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 4.399288e-3 |
GO:0030510 | regulation of BMP signaling pathway | 4.454807e-3 |
GO:0009143 | nucleoside triphosphate catabolic process | 4.669113e-3 |
GO:0051036 | regulation of endosome size | 4.676049e-3 |
GO:0046426 | negative regulation of JAK-STAT cascade | 4.959565e-3 |
GO:0071459 | protein localization to chromosome, centromeric region | 4.983462e-3 |
GO:0033590 | response to cobalamin | 4.983462e-3 |
GO:0006117 | acetaldehyde metabolic process | 4.983462e-3 |
GO:0030187 | melatonin biosynthetic process | 4.983462e-3 |
GO:0009438 | methylglyoxal metabolic process | 4.983462e-3 |
GO:0032042 | mitochondrial DNA metabolic process | 5.108695e-3 |
GO:0007130 | synaptonemal complex assembly | 5.113925e-3 |
GO:0033031 | positive regulation of neutrophil apoptosis | 5.185617e-3 |
GO:0070165 | positive regulation of adiponectin secretion | 5.185617e-3 |
GO:0035767 | endothelial cell chemotaxis | 5.388032e-3 |
GO:0006094 | gluconeogenesis | 5.489701e-3 |
GO:0007210 | serotonin receptor signaling pathway | 5.543773e-3 |
GO:0030540 | female genitalia development | 5.543773e-3 |
GO:0050832 | defense response to fungus | 5.549506e-3 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 5.595230e-3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 5.617423e-3 |
GO:0032513 | negative regulation of protein phosphatase type 2B activity | 5.649043e-3 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 5.723729e-3 |
GO:0051260 | protein homooligomerization | 5.764666e-3 |
GO:0032402 | melanosome transport | 5.868732e-3 |
GO:0072054 | renal outer medulla development | 5.885036e-3 |
GO:0072053 | renal inner medulla development | 5.885036e-3 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 5.885036e-3 |
GO:0021571 | rhombomere 5 development | 5.885036e-3 |
GO:0009259 | ribonucleotide metabolic process | 5.903075e-3 |
GO:0006184 | GTP catabolic process | 5.970541e-3 |
GO:0006984 | ER-nucleus signaling pathway | 5.988837e-3 |
GO:0032959 | inositol trisphosphate biosynthetic process | 6.047924e-3 |
GO:0071479 | cellular response to ionizing radiation | 6.100647e-3 |
GO:0002686 | negative regulation of leukocyte migration | 6.139302e-3 |
GO:0019062 | virion attachment to host cell surface receptor | 6.182703e-3 |
GO:0001906 | cell killing | 6.207060e-3 |
GO:0051972 | regulation of telomerase activity | 6.211474e-3 |
GO:0043242 | negative regulation of protein complex disassembly | 6.260064e-3 |
GO:0001558 | regulation of cell growth | 6.307360e-3 |
GO:0072012 | glomerulus vasculature development | 6.447525e-3 |
GO:0033002 | muscle cell proliferation | 6.578372e-3 |
GO:0032689 | negative regulation of interferon-gamma production | 6.632181e-3 |
GO:0045658 | regulation of neutrophil differentiation | 6.634885e-3 |
GO:0001732 | formation of translation initiation complex | 6.634885e-3 |
GO:0043299 | leukocyte degranulation | 6.673615e-3 |
GO:0030149 | sphingolipid catabolic process | 6.673615e-3 |
GO:0006383 | transcription from RNA polymerase III promoter | 6.730374e-3 |
GO:0015805 | S-adenosylmethionine transport | 6.741572e-3 |
GO:0002765 | immune response-inhibiting signal transduction | 6.741572e-3 |
GO:0031103 | axon regeneration | 6.780643e-3 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 6.913707e-3 |
GO:0006195 | purine nucleotide catabolic process | 6.957829e-3 |
GO:0050860 | negative regulation of T cell receptor signaling pathway | 7.018537e-3 |
GO:0007028 | cytoplasm organization | 7.041834e-3 |
GO:0055017 | cardiac muscle tissue growth | 7.198026e-3 |
GO:0060535 | trachea cartilage morphogenesis | 7.205846e-3 |
GO:0072089 | stem cell proliferation | 7.205846e-3 |
GO:0033687 | osteoblast proliferation | 7.205846e-3 |
GO:0006561 | proline biosynthetic process | 7.205846e-3 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 7.313963e-3 |
GO:0090192 | regulation of glomerulus development | 7.530590e-3 |
GO:0032273 | positive regulation of protein polymerization | 7.550480e-3 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 7.650990e-3 |
GO:0051102 | DNA ligation involved in DNA recombination | 7.658296e-3 |
GO:0006425 | glutaminyl-tRNA aminoacylation | 7.658296e-3 |
GO:0071243 | cellular response to arsenic-containing substance | 7.690159e-3 |
GO:0009395 | phospholipid catabolic process | 7.762367e-3 |
GO:0000080 | G1 phase of mitotic cell cycle | 7.765959e-3 |
GO:0048024 | regulation of nuclear mRNA splicing, via spliceosome | 7.935321e-3 |
GO:0070358 | actin polymerization-dependent cell motility | 7.950921e-3 |
GO:0060343 | trabecula formation | 7.995030e-3 |
GO:0003229 | ventricular cardiac muscle tissue development | 8.015681e-3 |
GO:0032792 | negative regulation of CREB transcription factor activity | 8.024581e-3 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 8.388084e-3 |
GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway | 8.436896e-3 |
GO:0003416 | endochondral bone growth | 8.563612e-3 |
GO:0060419 | heart growth | 8.598315e-3 |
GO:0043933 | macromolecular complex subunit organization | 8.627311e-3 |
GO:0043623 | cellular protein complex assembly | 8.688317e-3 |
GO:0043697 | cell dedifferentiation | 8.728357e-3 |
GO:2000773 | negative regulation of cellular senescence | 8.728357e-3 |
GO:0046039 | GTP metabolic process | 8.822507e-3 |
GO:0048483 | autonomic nervous system development | 8.849520e-3 |
GO:0006982 | response to lipid hydroperoxide | 9.090396e-3 |
GO:0061180 | mammary gland epithelium development | 9.185093e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 9.195943e-3 |
GO:0046320 | regulation of fatty acid oxidation | 9.247121e-3 |
GO:0072181 | mesonephric duct formation | 9.279737e-3 |
GO:0042138 | meiotic DNA double-strand break formation | 9.279737e-3 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 9.279737e-3 |
GO:0033313 | meiotic cell cycle checkpoint | 9.279737e-3 |
GO:0070271 | protein complex biogenesis | 9.353283e-3 |
GO:0046466 | membrane lipid catabolic process | 9.366574e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 9.575541e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 9.594235e-3 |
GO:0051904 | pigment granule transport | 9.743341e-3 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 9.810622e-3 |
GO:0072384 | organelle transport along microtubule | 9.879506e-3 |
GO:0048535 | lymph node development | 9.931126e-3 |
GO:0033233 | regulation of protein sumoylation | 1.006772e-2 |
GO:0072111 | cell proliferation involved in kidney development | 1.020061e-2 |
GO:0045926 | negative regulation of growth | 1.033829e-2 |
GO:0009166 | nucleotide catabolic process | 1.036707e-2 |
GO:0050687 | negative regulation of defense response to virus | 1.046819e-2 |
GO:0032222 | regulation of synaptic transmission, cholinergic | 1.046819e-2 |
GO:0032793 | positive regulation of CREB transcription factor activity | 1.047409e-2 |
GO:0072355 | histone H3-T3 phosphorylation | 1.055636e-2 |
GO:0015706 | nitrate transport | 1.055636e-2 |
GO:0010571 | positive regulation of DNA replication involved in S phase | 1.055636e-2 |
GO:0035880 | embryonic nail plate morphogenesis | 1.056209e-2 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 1.073028e-2 |
GO:0060688 | regulation of morphogenesis of a branching structure | 1.081400e-2 |
GO:0010669 | epithelial structure maintenance | 1.088477e-2 |
GO:0042594 | response to starvation | 1.089642e-2 |
GO:0001763 | morphogenesis of a branching structure | 1.091422e-2 |
GO:0046165 | alcohol biosynthetic process | 1.098156e-2 |
GO:0006878 | cellular copper ion homeostasis | 1.104606e-2 |
GO:0043270 | positive regulation of ion transport | 1.112395e-2 |
GO:0030490 | maturation of SSU-rRNA | 1.114431e-2 |
GO:0018026 | peptidyl-lysine monomethylation | 1.114431e-2 |
GO:0072523 | purine-containing compound catabolic process | 1.133628e-2 |
GO:0008333 | endosome to lysosome transport | 1.140192e-2 |
GO:0001714 | endodermal cell fate specification | 1.152405e-2 |
GO:0016049 | cell growth | 1.162330e-2 |
GO:0032740 | positive regulation of interleukin-17 production | 1.166479e-2 |
GO:0060675 | ureteric bud morphogenesis | 1.168446e-2 |
GO:0001657 | ureteric bud development | 1.194902e-2 |
GO:0048521 | negative regulation of behavior | 1.201390e-2 |
GO:2000543 | positive regulation of gastrulation | 1.202965e-2 |
GO:0001656 | metanephros development | 1.208844e-2 |
GO:0015827 | tryptophan transport | 1.214723e-2 |
GO:0032700 | negative regulation of interleukin-17 production | 1.226401e-2 |
GO:0022617 | extracellular matrix disassembly | 1.228848e-2 |
GO:0051257 | spindle midzone assembly involved in meiosis | 1.230444e-2 |
GO:0009235 | cobalamin metabolic process | 1.230444e-2 |
GO:0007060 | male meiosis chromosome segregation | 1.230444e-2 |
GO:0055008 | cardiac muscle tissue morphogenesis | 1.234726e-2 |
GO:0021559 | trigeminal nerve development | 1.250862e-2 |
GO:0050686 | negative regulation of mRNA processing | 1.255136e-2 |
GO:0032543 | mitochondrial translation | 1.255136e-2 |
GO:0019348 | dolichol metabolic process | 1.268167e-2 |
GO:0034698 | response to gonadotropin stimulus | 1.298387e-2 |
GO:0048672 | positive regulation of collateral sprouting | 1.300302e-2 |
GO:0006000 | fructose metabolic process | 1.300822e-2 |
GO:0034622 | cellular macromolecular complex assembly | 1.310776e-2 |
GO:0060534 | trachea cartilage development | 1.315214e-2 |
GO:0050651 | dermatan sulfate proteoglycan biosynthetic process | 1.315214e-2 |
GO:0048265 | response to pain | 1.316381e-2 |
GO:0065003 | macromolecular complex assembly | 1.324759e-2 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 1.337869e-2 |
GO:0050806 | positive regulation of synaptic transmission | 1.346599e-2 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.358243e-2 |
GO:0072009 | nephron epithelium development | 1.370162e-2 |
GO:0051081 | nuclear envelope disassembly | 1.383591e-2 |
GO:0035694 | mitochondrial protein catabolic process | 1.383591e-2 |
GO:0061015 | snRNA import into nucleus | 1.385864e-2 |
GO:0001880 | Mullerian duct regression | 1.389857e-2 |
GO:0046293 | formaldehyde biosynthetic process | 1.400376e-2 |
GO:0060133 | somatotropin secreting cell development | 1.400376e-2 |
GO:0043152 | induction of bacterial agglutination | 1.400376e-2 |
GO:0051966 | regulation of synaptic transmission, glutamatergic | 1.401923e-2 |
GO:0002449 | lymphocyte mediated immunity | 1.416243e-2 |
GO:0000302 | response to reactive oxygen species | 1.420796e-2 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.421591e-2 |
GO:0072148 | epithelial cell fate commitment | 1.421591e-2 |
GO:0032414 | positive regulation of ion transmembrane transporter activity | 1.430595e-2 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.475413e-2 |
GO:0032401 | establishment of melanosome localization | 1.481858e-2 |
GO:0060596 | mammary placode formation | 1.482651e-2 |
GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein | 1.483464e-2 |
GO:0060173 | limb development | 1.522296e-2 |
GO:0060433 | bronchus development | 1.541127e-2 |
GO:0072298 | regulation of metanephric glomerulus development | 1.541127e-2 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 1.545697e-2 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 1.545697e-2 |
GO:0050655 | dermatan sulfate proteoglycan metabolic process | 1.545697e-2 |
GO:0039003 | pronephric field specification | 1.545697e-2 |
GO:0048738 | cardiac muscle tissue development | 1.562223e-2 |
GO:0051318 | G1 phase | 1.578629e-2 |
GO:0000239 | pachytene | 1.581195e-2 |
GO:0003051 | angiotensin-mediated drinking behavior | 1.582946e-2 |
GO:0019047 | provirus integration | 1.587797e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0045780 | positive regulation of bone resorption | 1.420312e-11 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 1.746931e-10 |
GO:0034105 | positive regulation of tissue remodeling | 8.749481e-10 |
GO:0030502 | negative regulation of bone mineralization | 2.569866e-9 |
GO:0070168 | negative regulation of biomineral tissue development | 3.250123e-9 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 1.079422e-8 |
GO:0045124 | regulation of bone resorption | 1.932325e-8 |
GO:0006936 | muscle contraction | 2.381440e-8 |
GO:0048496 | maintenance of organ identity | 3.346899e-8 |
GO:0046850 | regulation of bone remodeling | 5.280895e-8 |
GO:0009236 | cobalamin biosynthetic process | 6.022777e-8 |
GO:0006953 | acute-phase response | 1.169967e-7 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 1.579771e-7 |
GO:0031100 | organ regeneration | 5.404450e-7 |
GO:0007059 | chromosome segregation | 5.930278e-7 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 7.413020e-7 |
GO:0031987 | locomotion involved in locomotory behavior | 1.206404e-6 |
GO:0046626 | regulation of insulin receptor signaling pathway | 3.616568e-6 |
GO:0090231 | regulation of spindle checkpoint | 4.019155e-6 |
GO:0046341 | CDP-diacylglycerol metabolic process | 4.412856e-6 |
GO:0031161 | phosphatidylinositol catabolic process | 5.027169e-6 |
GO:0060986 | endocrine hormone secretion | 7.030690e-6 |
GO:0034337 | RNA folding | 7.110288e-6 |
GO:0034103 | regulation of tissue remodeling | 7.477467e-6 |
GO:0070166 | enamel mineralization | 7.484708e-6 |
GO:0061301 | cerebellum vasculature morphogenesis | 7.548455e-6 |
GO:0045210 | FasL biosynthetic process | 7.548455e-6 |
GO:0006348 | chromatin silencing at telomere | 7.650979e-6 |
GO:0044029 | hypomethylation of CpG island | 1.220624e-5 |
GO:0032846 | positive regulation of homeostatic process | 1.525064e-5 |
GO:0045948 | positive regulation of translational initiation | 1.578014e-5 |
GO:0050766 | positive regulation of phagocytosis | 1.838390e-5 |
GO:0018206 | peptidyl-methionine modification | 2.050036e-5 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.331510e-5 |
GO:0021987 | cerebral cortex development | 2.381616e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 2.512803e-5 |
GO:2000279 | negative regulation of DNA biosynthetic process | 2.778756e-5 |
GO:0046960 | sensitization | 2.876436e-5 |
GO:0007076 | mitotic chromosome condensation | 3.010589e-5 |
GO:0002526 | acute inflammatory response | 3.234128e-5 |
GO:0030308 | negative regulation of cell growth | 3.289150e-5 |
GO:0050764 | regulation of phagocytosis | 4.069736e-5 |
GO:0030263 | apoptotic chromosome condensation | 4.634857e-5 |
GO:0030279 | negative regulation of ossification | 4.839492e-5 |
GO:0003012 | muscle system process | 4.936762e-5 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 5.900484e-5 |
GO:0044030 | regulation of DNA methylation | 5.997888e-5 |
GO:0032402 | melanosome transport | 6.216704e-5 |
GO:0006941 | striated muscle contraction | 6.453133e-5 |
GO:0048633 | positive regulation of skeletal muscle tissue growth | 6.569273e-5 |
GO:0031099 | regeneration | 6.802116e-5 |
GO:0070986 | left/right axis specification | 7.416928e-5 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 8.760720e-5 |
GO:0009235 | cobalamin metabolic process | 9.216508e-5 |
GO:0035106 | operant conditioning | 9.340357e-5 |
GO:0006370 | mRNA capping | 9.373235e-5 |
GO:0000028 | ribosomal small subunit assembly | 1.017542e-4 |
GO:0015992 | proton transport | 1.268675e-4 |
GO:0032800 | receptor biosynthetic process | 1.334633e-4 |
GO:0043049 | otic placode formation | 1.380418e-4 |
GO:0006818 | hydrogen transport | 1.443518e-4 |
GO:0021636 | trigeminal nerve morphogenesis | 1.451654e-4 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 1.451654e-4 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 1.463473e-4 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 1.463473e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 1.463473e-4 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 1.463473e-4 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 1.463473e-4 |
GO:0022618 | ribonucleoprotein complex assembly | 1.721092e-4 |
GO:0042640 | anagen | 1.748721e-4 |
GO:0003148 | outflow tract septum morphogenesis | 1.749273e-4 |
GO:0060972 | left/right pattern formation | 2.671110e-4 |
GO:0051904 | pigment granule transport | 2.671110e-4 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 2.671110e-4 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 2.827744e-4 |
GO:0060286 | flagellar cell motility | 2.919194e-4 |
GO:0006601 | creatine biosynthetic process | 2.919194e-4 |
GO:0071826 | ribonucleoprotein complex subunit organization | 3.077729e-4 |
GO:0042274 | ribosomal small subunit biogenesis | 3.454161e-4 |
GO:0009452 | RNA capping | 3.523389e-4 |
GO:0032401 | establishment of melanosome localization | 3.552895e-4 |
GO:0007080 | mitotic metaphase plate congression | 3.552895e-4 |
GO:0032274 | gonadotropin secretion | 3.640759e-4 |
GO:0035426 | extracellular matrix-cell signaling | 3.831357e-4 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 3.839003e-4 |
GO:0031365 | N-terminal protein amino acid modification | 3.871575e-4 |
GO:0021895 | cerebral cortex neuron differentiation | 4.145649e-4 |
GO:0000070 | mitotic sister chromatid segregation | 4.322167e-4 |
GO:0048631 | regulation of skeletal muscle tissue growth | 4.606942e-4 |
GO:0032400 | melanosome localization | 4.845019e-4 |
GO:0021543 | pallium development | 4.854135e-4 |
GO:2000171 | negative regulation of dendrite development | 5.124227e-4 |
GO:0048643 | positive regulation of skeletal muscle tissue development | 5.180843e-4 |
GO:0060371 | regulation of atrial cardiomyocyte membrane depolarization | 5.527212e-4 |
GO:0061304 | retinal blood vessel morphogenesis | 5.881663e-4 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 6.370132e-4 |
GO:0040030 | regulation of molecular function, epigenetic | 6.720007e-4 |
GO:0048672 | positive regulation of collateral sprouting | 6.720007e-4 |
GO:0009957 | epidermal cell fate specification | 6.720007e-4 |
GO:0048820 | hair follicle maturation | 7.020572e-4 |
GO:0032908 | regulation of transforming growth factor beta1 production | 7.386167e-4 |
GO:2000278 | regulation of DNA biosynthetic process | 7.712180e-4 |
GO:0045746 | negative regulation of Notch signaling pathway | 7.712180e-4 |
GO:0000819 | sister chromatid segregation | 7.997461e-4 |
GO:0097152 | mesenchymal cell apoptosis | 8.275811e-4 |
GO:0046958 | nonassociative learning | 8.294566e-4 |
GO:0045930 | negative regulation of mitotic cell cycle | 8.402849e-4 |
GO:0007191 | activation of adenylate cyclase activity by dopamine receptor signaling pathway | 8.660838e-4 |
GO:0021997 | neural plate axis specification | 9.884645e-4 |
GO:0051905 | establishment of pigment granule localization | 1.040475e-3 |
GO:0006054 | N-acetylneuraminate metabolic process | 1.040475e-3 |
GO:0048640 | negative regulation of developmental growth | 1.078404e-3 |
GO:0046605 | regulation of centrosome cycle | 1.090338e-3 |
GO:0035239 | tube morphogenesis | 1.106616e-3 |
GO:0042384 | cilium assembly | 1.114175e-3 |
GO:0042989 | sequestering of actin monomers | 1.119745e-3 |
GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation | 1.121239e-3 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 1.121239e-3 |
GO:0006587 | serotonin biosynthetic process from tryptophan | 1.150037e-3 |
GO:0051875 | pigment granule localization | 1.160142e-3 |
GO:0046381 | CMP-N-acetylneuraminate metabolic process | 1.176541e-3 |
GO:0042254 | ribosome biogenesis | 1.329560e-3 |
GO:0050886 | endocrine process | 1.336682e-3 |
GO:0043201 | response to leucine | 1.368560e-3 |
GO:0071922 | regulation of cohesin localization to chromatin | 1.375465e-3 |
GO:0071635 | negative regulation of transforming growth factor beta production | 1.386255e-3 |
GO:0060896 | neural plate pattern specification | 1.386255e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 1.519035e-3 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 1.564434e-3 |
GO:0016601 | Rac protein signal transduction | 1.665417e-3 |
GO:0007063 | regulation of sister chromatid cohesion | 1.699847e-3 |
GO:0010388 | cullin deneddylation | 1.699953e-3 |
GO:0008361 | regulation of cell size | 1.775884e-3 |
GO:0006379 | mRNA cleavage | 1.786265e-3 |
GO:0048148 | behavioral response to cocaine | 1.881709e-3 |
GO:0003127 | detection of nodal flow | 1.886994e-3 |
GO:0030500 | regulation of bone mineralization | 1.895174e-3 |
GO:0021602 | cranial nerve morphogenesis | 1.946140e-3 |
GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein | 1.962062e-3 |
GO:0061387 | regulation of extent of cell growth | 2.155559e-3 |
GO:0045494 | photoreceptor cell maintenance | 2.244428e-3 |
GO:0006552 | leucine catabolic process | 2.269921e-3 |
GO:0031104 | dendrite regeneration | 2.269921e-3 |
GO:0045234 | protein palmitoleylation | 2.269921e-3 |
GO:0006948 | induction by virus of host cell-cell fusion | 2.269921e-3 |
GO:0048671 | negative regulation of collateral sprouting | 2.287244e-3 |
GO:0006096 | glycolysis | 2.315785e-3 |
GO:0032971 | regulation of muscle filament sliding | 2.366523e-3 |
GO:0090084 | negative regulation of inclusion body assembly | 2.413883e-3 |
GO:0070286 | axonemal dynein complex assembly | 2.413883e-3 |
GO:0021545 | cranial nerve development | 2.427980e-3 |
GO:0051310 | metaphase plate congression | 2.490106e-3 |
GO:0070167 | regulation of biomineral tissue development | 2.490152e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 2.598531e-3 |
GO:0010460 | positive regulation of heart rate | 2.681853e-3 |
GO:0050808 | synapse organization | 2.683047e-3 |
GO:0001542 | ovulation from ovarian follicle | 2.715559e-3 |
GO:0060285 | ciliary cell motility | 2.742153e-3 |
GO:0002074 | extraocular skeletal muscle development | 2.742153e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 2.752846e-3 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 2.844867e-3 |
GO:0010273 | detoxification of copper ion | 2.914959e-3 |
GO:0042701 | progesterone secretion | 3.009691e-3 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 3.099718e-3 |
GO:0032868 | response to insulin stimulus | 3.140155e-3 |
GO:0033148 | positive regulation of estrogen receptor signaling pathway | 3.283376e-3 |
GO:0003065 | positive regulation of heart rate by epinephrine | 3.283376e-3 |
GO:0015986 | ATP synthesis coupled proton transport | 3.307361e-3 |
GO:0040019 | positive regulation of embryonic development | 3.382855e-3 |
GO:0042396 | phosphagen biosynthetic process | 3.487802e-3 |
GO:0010833 | telomere maintenance via telomere lengthening | 3.487802e-3 |
GO:0006269 | DNA replication, synthesis of RNA primer | 3.487802e-3 |
GO:0006542 | glutamine biosynthetic process | 3.487802e-3 |
GO:0006406 | mRNA export from nucleus | 3.505841e-3 |
GO:0021570 | rhombomere 4 development | 3.535309e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 3.536391e-3 |
GO:0006446 | regulation of translational initiation | 3.674911e-3 |
GO:0045213 | neurotransmitter receptor metabolic process | 3.739055e-3 |
GO:0060982 | coronary artery morphogenesis | 3.883697e-3 |
GO:0021853 | cerebral cortex GABAergic interneuron migration | 3.907602e-3 |
GO:0051303 | establishment of chromosome localization | 3.950414e-3 |
GO:0030262 | apoptotic nuclear change | 3.993393e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 4.202888e-3 |
GO:0050685 | positive regulation of mRNA processing | 4.204332e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 4.211543e-3 |
GO:0046813 | virion attachment, binding of host cell surface receptor | 4.230322e-3 |
GO:0042448 | progesterone metabolic process | 4.320892e-3 |
GO:0021796 | cerebral cortex regionalization | 4.360293e-3 |
GO:0045844 | positive regulation of striated muscle tissue development | 4.624828e-3 |
GO:0032413 | negative regulation of ion transmembrane transporter activity | 4.639008e-3 |
GO:0007413 | axonal fasciculation | 4.703162e-3 |
GO:0021564 | vagus nerve development | 4.767258e-3 |
GO:0060486 | Clara cell differentiation | 4.825862e-3 |
GO:0000082 | G1/S transition of mitotic cell cycle | 4.848848e-3 |
GO:0061338 | atrioventricular node impulse conduction delay | 4.887498e-3 |
GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 5.002492e-3 |
GO:0045807 | positive regulation of endocytosis | 5.045949e-3 |
GO:0060017 | parathyroid gland development | 5.313027e-3 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 5.368896e-3 |
GO:0046475 | glycerophospholipid catabolic process | 5.368896e-3 |
GO:0045039 | protein import into mitochondrial inner membrane | 5.368896e-3 |
GO:0046323 | glucose import | 5.368896e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 5.513594e-3 |
GO:0071600 | otic vesicle morphogenesis | 5.515417e-3 |
GO:0046339 | diacylglycerol metabolic process | 5.693181e-3 |
GO:2000121 | regulation of removal of superoxide radicals | 5.721480e-3 |
GO:0010501 | RNA secondary structure unwinding | 5.854079e-3 |
GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response | 5.854079e-3 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 5.913108e-3 |
GO:0060033 | anatomical structure regression | 5.957241e-3 |
GO:0007368 | determination of left/right symmetry | 5.986206e-3 |
GO:0070327 | thyroid hormone transport | 6.151555e-3 |
GO:0006650 | glycerophospholipid metabolic process | 6.263172e-3 |
GO:0042438 | melanin biosynthetic process | 6.282875e-3 |
GO:0042255 | ribosome assembly | 6.282875e-3 |
GO:0006654 | phosphatidic acid biosynthetic process | 6.282875e-3 |
GO:0051180 | vitamin transport | 6.325364e-3 |
GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 6.377071e-3 |
GO:0021843 | substrate-independent telencephalic tangential interneuron migration | 6.522412e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 6.603829e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 6.603829e-3 |
GO:0051329 | interphase of mitotic cell cycle | 6.697662e-3 |
GO:0003015 | heart process | 6.775973e-3 |
GO:0008380 | RNA splicing | 6.777028e-3 |
GO:0046168 | glycerol-3-phosphate catabolic process | 6.787112e-3 |
GO:0035880 | embryonic nail plate morphogenesis | 6.787112e-3 |
GO:0006658 | phosphatidylserine metabolic process | 6.794499e-3 |
GO:0006921 | cellular component disassembly involved in apoptosis | 6.837617e-3 |
GO:0045823 | positive regulation of heart contraction | 6.842977e-3 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 7.156125e-3 |
GO:0033119 | negative regulation of RNA splicing | 7.184855e-3 |
GO:0043501 | skeletal muscle adaptation | 7.251084e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 7.591152e-3 |
GO:0007064 | mitotic sister chromatid cohesion | 7.591152e-3 |
GO:0021559 | trigeminal nerve development | 7.591152e-3 |
GO:0032972 | regulation of muscle filament sliding speed | 7.637371e-3 |
GO:0001708 | cell fate specification | 7.639036e-3 |
GO:0009799 | specification of symmetry | 7.723016e-3 |
GO:0070474 | positive regulation of uterine smooth muscle contraction | 7.829132e-3 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 7.902643e-3 |
GO:0030261 | chromosome condensation | 7.960088e-3 |
GO:0007617 | mating behavior | 8.012199e-3 |
GO:0048011 | nerve growth factor receptor signaling pathway | 8.099505e-3 |
GO:0048193 | Golgi vesicle transport | 8.108840e-3 |
GO:0016525 | negative regulation of angiogenesis | 8.176477e-3 |
GO:0051795 | positive regulation of catagen | 8.542385e-3 |
GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process | 8.904551e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 8.907861e-3 |
GO:0048818 | positive regulation of hair follicle maturation | 9.296797e-3 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 9.296797e-3 |
GO:0061337 | cardiac conduction | 9.512504e-3 |
GO:0048670 | regulation of collateral sprouting | 9.815016e-3 |
GO:0002027 | regulation of heart rate | 9.877738e-3 |
GO:0051325 | interphase | 9.959523e-3 |
GO:0071375 | cellular response to peptide hormone stimulus | 1.000230e-2 |
GO:0032938 | negative regulation of translation in response to oxidative stress | 1.005056e-2 |
GO:2001051 | positive regulation of tendon cell differentiation | 1.005056e-2 |
GO:0021509 | roof plate formation | 1.005056e-2 |
GO:0030578 | PML body organization | 1.005056e-2 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 1.005056e-2 |
GO:0045014 | negative regulation of transcription by glucose | 1.009325e-2 |
GO:0003266 | regulation of secondary heart field cardioblast proliferation | 1.014593e-2 |
GO:0021783 | preganglionic parasympathetic nervous system development | 1.092413e-2 |
GO:0051567 | histone H3-K9 methylation | 1.108789e-2 |
GO:0048639 | positive regulation of developmental growth | 1.108814e-2 |
GO:0002009 | morphogenesis of an epithelium | 1.122038e-2 |
GO:0033762 | response to glucagon stimulus | 1.134143e-2 |
GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein | 1.134143e-2 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 1.136686e-2 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 1.136686e-2 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 1.136686e-2 |
GO:0019062 | virion attachment to host cell surface receptor | 1.136686e-2 |
GO:0015872 | dopamine transport | 1.145702e-2 |
GO:0046532 | regulation of photoreceptor cell differentiation | 1.145702e-2 |
GO:0009084 | glutamine family amino acid biosynthetic process | 1.145702e-2 |
GO:0043954 | cellular component maintenance | 1.153643e-2 |
GO:0072337 | modified amino acid transport | 1.175861e-2 |
GO:0048708 | astrocyte differentiation | 1.191899e-2 |
GO:0051276 | chromosome organization | 1.192010e-2 |
GO:0001558 | regulation of cell growth | 1.195674e-2 |
GO:0030517 | negative regulation of axon extension | 1.219410e-2 |
GO:0030728 | ovulation | 1.244737e-2 |
GO:0072321 | chaperone-mediated protein transport | 1.273026e-2 |
GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development | 1.273026e-2 |
GO:0006390 | transcription from mitochondrial promoter | 1.274305e-2 |
GO:0042843 | D-xylose catabolic process | 1.275417e-2 |
GO:0045684 | positive regulation of epidermis development | 1.275620e-2 |
GO:0030217 | T cell differentiation | 1.315199e-2 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 1.321106e-2 |
GO:0014821 | phasic smooth muscle contraction | 1.356002e-2 |
GO:0030278 | regulation of ossification | 1.366478e-2 |
GO:0003254 | regulation of membrane depolarization | 1.368780e-2 |
GO:0072348 | sulfur compound transport | 1.371568e-2 |
GO:2000008 | regulation of protein localization at cell surface | 1.371568e-2 |
GO:0030432 | peristalsis | 1.383523e-2 |
GO:0006405 | RNA export from nucleus | 1.390141e-2 |
GO:0072109 | glomerular mesangium development | 1.396167e-2 |
GO:0072061 | inner medullary collecting duct development | 1.418304e-2 |
GO:0072060 | outer medullary collecting duct development | 1.418304e-2 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 1.418304e-2 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1.418304e-2 |
GO:0019405 | alditol catabolic process | 1.418304e-2 |
GO:0021644 | vagus nerve morphogenesis | 1.418304e-2 |
GO:0060428 | lung epithelium development | 1.436511e-2 |
GO:0051926 | negative regulation of calcium ion transport | 1.456473e-2 |
GO:0019067 | viral assembly, maturation, egress, and release | 1.475120e-2 |
GO:0048521 | negative regulation of behavior | 1.499753e-2 |
GO:0007613 | memory | 1.543549e-2 |
GO:0006582 | melanin metabolic process | 1.551394e-2 |
GO:0000723 | telomere maintenance | 1.555057e-2 |
GO:0031929 | TOR signaling cascade | 1.557006e-2 |
GO:0060048 | cardiac muscle contraction | 1.571167e-2 |
GO:0003051 | angiotensin-mediated drinking behavior | 1.572589e-2 |
GO:0051643 | endoplasmic reticulum localization | 1.572589e-2 |
GO:0071502 | cellular response to temperature stimulus | 1.573581e-2 |
GO:0048243 | norepinephrine secretion | 1.573581e-2 |
GO:0014827 | intestine smooth muscle contraction | 1.573581e-2 |
GO:0044275 | cellular carbohydrate catabolic process | 1.576267e-2 |
GO:0032869 | cellular response to insulin stimulus | 1.622792e-2 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.663977e-2 |
GO:0021515 | cell differentiation in spinal cord | 1.683818e-2 |
GO:0008050 | female courtship behavior | 1.691131e-2 |
GO:0048486 | parasympathetic nervous system development | 1.693746e-2 |
GO:0046782 | regulation of viral transcription | 1.720157e-2 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.735936e-2 |
GO:0048251 | elastic fiber assembly | 1.801628e-2 |
GO:0061113 | pancreas morphogenesis | 1.807114e-2 |
GO:0007221 | positive regulation of transcription of Notch receptor target | 1.807114e-2 |
GO:0032844 | regulation of homeostatic process | 1.874334e-2 |
GO:0048843 | negative regulation of axon extension involved in axon guidance | 1.878851e-2 |
GO:0051983 | regulation of chromosome segregation | 1.892060e-2 |
GO:0048857 | neural nucleus development | 1.892060e-2 |
GO:0071934 | thiamine transmembrane transport | 1.898350e-2 |
GO:0043420 | anthranilate metabolic process | 1.898350e-2 |
GO:0000053 | argininosuccinate metabolic process | 1.898350e-2 |
GO:0034516 | response to vitamin B6 | 1.898350e-2 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.908383e-2 |
GO:0061298 | retina vasculature development in camera-type eye | 1.914710e-2 |
GO:0046533 | negative regulation of photoreceptor cell differentiation | 1.914710e-2 |
GO:0090083 | regulation of inclusion body assembly | 1.927919e-2 |
GO:0015991 | ATP hydrolysis coupled proton transport | 1.958062e-2 |
GO:0048483 | autonomic nervous system development | 1.966373e-2 |
GO:0070125 | mitochondrial translational elongation | 1.971326e-2 |
GO:0060562 | epithelial tube morphogenesis | 2.000368e-2 |
GO:0042053 | regulation of dopamine metabolic process | 2.011871e-2 |
GO:0014807 | regulation of somitogenesis | 2.089958e-2 |
GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 2.089958e-2 |
GO:0046784 | intronless viral mRNA export from host nucleus | 2.112200e-2 |
GO:0014823 | response to activity | 2.122248e-2 |
GO:0051937 | catecholamine transport | 2.143822e-2 |
GO:0032200 | telomere organization | 2.143822e-2 |
GO:0030837 | negative regulation of actin filament polymerization | 2.169952e-2 |
GO:0000959 | mitochondrial RNA metabolic process | 2.184192e-2 |
GO:0009914 | hormone transport | 2.206691e-2 |
GO:0033059 | cellular pigmentation | 2.231299e-2 |
GO:0006364 | rRNA processing | 2.232014e-2 |
GO:0018208 | peptidyl-proline modification | 2.233955e-2 |
GO:0019805 | quinolinate biosynthetic process | 2.248558e-2 |
GO:0000722 | telomere maintenance via recombination | 2.248558e-2 |
GO:0006278 | RNA-dependent DNA replication | 2.250966e-2 |
GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 2.250966e-2 |
GO:0050771 | negative regulation of axonogenesis | 2.255651e-2 |
GO:0046174 | polyol catabolic process | 2.280670e-2 |
GO:0001732 | formation of translation initiation complex | 2.280670e-2 |
GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation | 2.298902e-2 |
GO:0000245 | spliceosome assembly | 2.329724e-2 |
GO:0030516 | regulation of axon extension | 2.343736e-2 |
GO:0046365 | monosaccharide catabolic process | 2.353402e-2 |
GO:0021675 | nerve development | 2.373826e-2 |
GO:0048255 | mRNA stabilization | 2.376466e-2 |
GO:0001711 | endodermal cell fate commitment | 2.380805e-2 |
GO:0045926 | negative regulation of growth | 2.414269e-2 |
GO:0010977 | negative regulation of neuron projection development | 2.446970e-2 |
GO:0051924 | regulation of calcium ion transport | 2.450386e-2 |
GO:0045065 | cytotoxic T cell differentiation | 2.460300e-2 |
GO:0007493 | endodermal cell fate determination | 2.460300e-2 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 2.480521e-2 |
GO:0006467 | protein thiol-disulfide exchange | 2.480521e-2 |
GO:0001306 | age-dependent response to oxidative stress | 2.480521e-2 |
GO:0016577 | histone demethylation | 2.506868e-2 |
GO:0000278 | mitotic cell cycle | 2.520335e-2 |
GO:0030513 | positive regulation of BMP signaling pathway | 2.527942e-2 |
GO:0010224 | response to UV-B | 2.543803e-2 |
GO:0003272 | endocardial cushion formation | 2.545851e-2 |
GO:0019637 | organophosphate metabolic process | 2.603603e-2 |
GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 2.605884e-2 |
GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 2.605884e-2 |
GO:0021740 | principal sensory nucleus of trigeminal nerve development | 2.605884e-2 |
GO:0061141 | lung ciliated cell differentiation | 2.605884e-2 |
GO:0042733 | embryonic digit morphogenesis | 2.620570e-2 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 2.623078e-2 |
GO:0061143 | alveolar primary septum development | 2.623078e-2 |
GO:0002897 | positive regulation of central B cell tolerance induction | 2.623078e-2 |
GO:0002508 | central tolerance induction | 2.623078e-2 |
GO:0050434 | positive regulation of viral transcription | 2.639827e-2 |
GO:0042069 | regulation of catecholamine metabolic process | 2.662501e-2 |
GO:0021978 | telencephalon regionalization | 2.662501e-2 |
GO:0071218 | cellular response to misfolded protein | 2.689497e-2 |
GO:0018119 | peptidyl-cysteine S-nitrosylation | 2.689497e-2 |
GO:0048608 | reproductive structure development | 2.709848e-2 |
GO:0045668 | negative regulation of osteoblast differentiation | 2.722530e-2 |
GO:0007411 | axon guidance | 2.726640e-2 |
GO:0010838 | positive regulation of keratinocyte proliferation | 2.756531e-2 |
GO:0007619 | courtship behavior | 2.756531e-2 |
GO:0005513 | detection of calcium ion | 2.756531e-2 |
GO:0071526 | semaphorin-plexin signaling pathway | 2.777767e-2 |
GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 2.782737e-2 |
GO:0051282 | regulation of sequestering of calcium ion | 2.849292e-2 |
GO:0030900 | forebrain development | 2.857427e-2 |
GO:0021936 | regulation of cerebellar granule cell precursor proliferation | 2.880844e-2 |
GO:0090370 | negative regulation of cholesterol efflux | 2.907575e-2 |
GO:0042297 | vocal learning | 2.907575e-2 |
GO:0032902 | nerve growth factor production | 2.907575e-2 |
GO:0046015 | regulation of transcription by glucose | 2.912268e-2 |
GO:0007067 | mitosis | 2.939871e-2 |
GO:0060510 | Type II pneumocyte differentiation | 2.956462e-2 |
GO:0006882 | cellular zinc ion homeostasis | 2.984239e-2 |
GO:0085029 | extracellular matrix assembly | 2.986404e-2 |
GO:0048352 | paraxial mesoderm structural organization | 3.020815e-2 |
GO:0006433 | prolyl-tRNA aminoacylation | 3.020815e-2 |
GO:0021998 | neural plate mediolateral regionalization | 3.020815e-2 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 3.073117e-2 |
GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.091899e-2 |
GO:0006323 | DNA packaging | 3.155028e-2 |
GO:0007062 | sister chromatid cohesion | 3.156694e-2 |
GO:0006482 | protein demethylation | 3.156694e-2 |
GO:0042473 | outer ear morphogenesis | 3.162857e-2 |
GO:0034622 | cellular macromolecular complex assembly | 3.167311e-2 |
GO:0016072 | rRNA metabolic process | 3.199160e-2 |
GO:0009887 | organ morphogenesis | 3.209395e-2 |
GO:0071599 | otic vesicle development | 3.210419e-2 |
GO:0001503 | ossification | 3.226824e-2 |
GO:0006924 | activation-induced cell death of T cells | 3.239098e-2 |
GO:0035295 | tube development | 3.242131e-2 |
GO:0006261 | DNA-dependent DNA replication | 3.307259e-2 |
GO:0006644 | phospholipid metabolic process | 3.316702e-2 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.370885e-2 |
GO:0051612 | negative regulation of serotonin uptake | 3.370885e-2 |
GO:0042738 | exogenous drug catabolic process | 3.370885e-2 |
GO:0014732 | skeletal muscle atrophy | 3.410227e-2 |
GO:0060430 | lung saccule development | 3.433834e-2 |
GO:0030421 | defecation | 3.440710e-2 |
GO:0019442 | tryptophan catabolic process to acetyl-CoA | 3.440710e-2 |
GO:0006526 | arginine biosynthetic process | 3.440710e-2 |
GO:0018931 | naphthalene metabolic process | 3.440710e-2 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 3.473297e-2 |
GO:0006417 | regulation of translation | 3.486346e-2 |
GO:0022415 | viral reproductive process | 3.549523e-2 |
GO:0000087 | M phase of mitotic cell cycle | 3.555879e-2 |
GO:0048285 | organelle fission | 3.567061e-2 |
GO:0007512 | adult heart development | 3.571978e-2 |
GO:0055069 | zinc ion homeostasis | 3.577101e-2 |
GO:0008343 | adult feeding behavior | 3.586517e-2 |
GO:0021612 | facial nerve structural organization | 3.616019e-2 |
GO:0071400 | cellular response to oleic acid | 3.616019e-2 |
GO:0001840 | neural plate development | 3.718277e-2 |
GO:0071377 | cellular response to glucagon stimulus | 3.767977e-2 |
GO:0006600 | creatine metabolic process | 3.767977e-2 |
GO:0006007 | glucose catabolic process | 3.786774e-2 |
GO:2000179 | positive regulation of neural precursor cell proliferation | 3.847239e-2 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 3.859821e-2 |
GO:0072054 | renal outer medulla development | 3.870058e-2 |
GO:0001880 | Mullerian duct regression | 3.870058e-2 |
GO:0015805 | S-adenosylmethionine transport | 3.881736e-2 |
GO:0061146 | Peyer's patch morphogenesis | 3.903808e-2 |
GO:0001731 | formation of translation preinitiation complex | 3.903808e-2 |
GO:0007495 | visceral mesoderm-endoderm interaction involved in midgut development | 3.903808e-2 |
GO:0072044 | collecting duct development | 3.922357e-2 |
GO:0002051 | osteoblast fate commitment | 3.954612e-2 |
GO:0001661 | conditioned taste aversion | 3.954612e-2 |
GO:0019058 | viral infectious cycle | 3.959244e-2 |
GO:0060271 | cilium morphogenesis | 3.973799e-2 |
GO:0051496 | positive regulation of stress fiber assembly | 3.974618e-2 |
GO:0010629 | negative regulation of gene expression | 3.991769e-2 |
GO:0048752 | semicircular canal morphogenesis | 4.012710e-2 |
GO:0000724 | double-strand break repair via homologous recombination | 4.060359e-2 |
GO:0030050 | vesicle transport along actin filament | 4.132928e-2 |
GO:0048268 | clathrin coat assembly | 4.171651e-2 |
GO:0003219 | cardiac right ventricle formation | 4.171651e-2 |
GO:0003310 | pancreatic A cell differentiation | 4.171651e-2 |
GO:0051918 | negative regulation of fibrinolysis | 4.182314e-2 |
GO:0006901 | vesicle coating | 4.329856e-2 |
GO:0002635 | negative regulation of germinal center formation | 4.342897e-2 |
GO:0046502 | uroporphyrinogen III metabolic process | 4.342897e-2 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 4.342897e-2 |
GO:0033590 | response to cobalamin | 4.342897e-2 |
GO:0045924 | regulation of female receptivity | 4.343417e-2 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 4.361145e-2 |
GO:0071285 | cellular response to lithium ion | 4.361145e-2 |
GO:0071158 | positive regulation of cell cycle arrest | 4.411467e-2 |
GO:0016338 | calcium-independent cell-cell adhesion | 4.481916e-2 |
GO:0010898 | positive regulation of triglyceride catabolic process | 4.491616e-2 |
GO:0007292 | female gamete generation | 4.536219e-2 |
GO:0001706 | endoderm formation | 4.544419e-2 |
GO:0007625 | grooming behavior | 4.545581e-2 |
GO:0071634 | regulation of transforming growth factor beta production | 4.584097e-2 |
GO:0047497 | mitochondrion transport along microtubule | 4.592131e-2 |
GO:0001843 | neural tube closure | 4.624222e-2 |
GO:0090304 | nucleic acid metabolic process | 4.636793e-2 |
GO:0002663 | positive regulation of B cell tolerance induction | 4.684839e-2 |